Oral Administration of Imatinib to P230 BCR/ABL-Expressing Transgenic Mice Changes Clones with High BCR/ABL Complementary DNA Expression into Those with Low Expression
スポンサーリンク
概要
- 論文の詳細を見る
- 2006-11-15
著者
-
YAMAGUCHI Hiroki
Division of Hematology, Department of Internal Medicine, Nippon Medical School
-
INOKUCHI Koiti
Division of Hematology, Department of Internal Medicine, Nippon Medical School
-
WATANABE Ayako
Division of Hematology, Department of Internal Medicine, Nippon Medical School
-
DAN Kazuo
Division of Hematology, Department of Internal Medicine, Nippon Medical School
-
Dan K
Department Of Hematology Nippon Medical School
-
Dan Kazuo
Division Of Hematology Department Of Medicine Nippon Medical School
-
Watanabe Ayako
日本医科大学 医学部内科
-
Inokuchi Koiti
Department Of Internal Medicine Nippon Medical School
-
Inokuchi Koiti
Division Of Hematology Department Of Internal Medicine Nippon Medical School
-
Inami Mitsuharu
Division Of Hematology Department Of Third Internal Medicine Nippon Medical School
-
Ikebuchi Kenji
Department Of Hematology Nippon Medical School
-
Yamaguchi Hiroki
Department Of Hematology Nippon Medical School
-
TANOSAKI SAKAE
Division of Radiation Health, National Institute of Radiological Sciences
-
Tanosaki Sakae
Division Of Radiation Health National Institute Of Radiological Sciences
-
Tanosaki Sakae
Department Of Hematology The Fraternity Memorial Hospital
-
NAKAYAMA Kazutaka
Division of Hematology/Oncology, 3rd Department of Internal Medicine, Nippon Medical School
-
Nakayama Kazutaka
Division Of Hematology Department Of Third Internal Medicine Nippon Medical School
-
Watanabe Ayako
Division Of Hematology Department Of Third Internal Medicine Nippon Medical School
-
Dan Kazuo
Department Of Internal Medicine Nippon Medical School
-
UCHIDA Naoya
Division of Hematology, Department of Third Internal Medicine, Nippon Medical School
-
Uchida Naoya
Division Of Hematology Department Of Third Internal Medicine Nippon Medical School
-
Ito K
Department Of Hematology Nippon Medical School
-
Inokuchi Koiti
Nippon Medical School Tokyo Jpn
-
Watanabe Ayako
Division Of Applied Bioscience Graduate School Of Agriculture Hokkaido University:crest Japan Scienc
-
Watanabe Ayako
Division Of Hematology Department Of Medicine Nippon Medical School
-
Yamaguchi Hiroki
Division Of Hematology Department Of Internal Medicine Nippon Medical School
関連論文
- Virus removal from hemoglobin solution using Planova Membrane
- Philadelphia Chromosome-Positive Acute Myeloid Leukemia With Tetraploidy
- Refractory Facial Cellulitis Following Cosmetic Rhinoplasty After Cord-blood Stem Cell Transplantation
- Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
- Autologous bone marrow transplantation for patients with advanced chronic myelogenous leukemia
- Ex vivo large-scale generation of human red blood cells from cord blood CD34^+ cells by co-culturing with macrophages
- Photoinactivation of Vesicular Stomatitis Virus with Fullerene Conjugated with Methoxy Polyethylene Glycol Amine
- Virus Inactivation in Superoxide Dismutase Preparations by Ultraviolet Light Irradiation
- Photoinactivation of virus infectivity by hypocrellin A.
- Involvement of Reactive Oxygen Species in Hemoglobin Oxidation and Virus Inactivation by 1, 9-Dimethylmethylene Blue Phototreatment
- Lung Injury Associated with Bortezomib Therapy in Relapsed/Refractory Multiple Myeloma in Japan : A Questionnaire-Based Report from the "Lung Injury by Bortezomib" Joint Committee of the Japanese Society of Hematology and the Japanese Society of Clinical
- Current and future perspectives on the TARGET system : the registration system for Glivec^【○!R】 established by the JSH
- Initial Symptoms of Acute Radiation Syndrome in the JCO Criticality Accident in Tokai-mura
- Treatment of Patients who were Severely Exposed to Neutron and Gamma Radiation in the Recent Criticality Accident in Tokaimura
- Acquired hemophilia A may be associated with itraconazole
- Simultaneous Novel BCR-ABL Gene Mutation and Increased Expression of BCR-ABL mRNA Caused Clinical Resistance to STI571 in Double-Ph-Positive Acute Biphenotypic Leukemia
- Structural Confirmation of 15-Norlubiminol and 15-Norepilubiminol, Isolated from Solanum aethiopicum, by Chemical Conversion from Lubimin and Epilubimin, and their Antifungal Activity(Organic Chemistry)
- Alterations in the colorectal carcinoma gene and protein in a novel human myeloid leukemia cell line with trisomy 18 established from overt leukemia after myelodysplastic syndrome
- Pure White Cell Aplasia : Report of the First Case Associated with Primary Biliary Cirrhosis
- Oral Administration of Imatinib to P230 BCR/ABL-Expressing Transgenic Mice Changes Clones with High BCR/ABL Complementary DNA Expression into Those with Low Expression
- Small Cell Variant of T-Cell Prolymphocytic Leukemia with a γδ Immunophenotype
- Pseudo Gray Platelet Syndrome in a Patient with Acute Myocardial Infarction
- T-Cell Prolymphocytic Leukemia With Hemorrhagic Gastrointestinal Involvement and a New Chromosomal Abnormality
- Acute Lymphoblastic Leukemia with Isolated Adrenocorticotropic Hormone Deficiency
- Rationale and hematologic target points in response-oriented individualized induction chemotherapy for acute myeloid leukemia
- Herbal Medicine-Associated Lead Intoxication
- Analysis of Triglyceride Value in the Diagnosis and Treatment Response of Secondary Hemophagocytic Syndrome
- Clinical efficacy and safety of biapenem for febrile neutropenia in patients with underlying hematopoietic diseases : a multi-institutional study
- Importance of Relative Dose Intensity in Chemotherapy for Diffuse Large B-Cell Lymphoma
- P53 Germline Mutations and Therapy-related Myelodysplastic Syndrome
- RCSD1-ABL1-positive B lymphoblastic leukemia is sensitive to dexamethasone and tyrosine kinase inhibitors and rapidly evolves clonally by chromosomal translocations
- Pure red cell aplasia and Evans syndrome following hematopoietic stem cell transplantation from blood type-matched unrelated donor
- Harmonization of molecular monitoring of chronic myeloid leukemia therapy in Japan